MyAverix Finance
SHE · Healthcare
Amoy Diagnostics Co Ltd (300685)
Diagnostics & Research
Amoy Diagnostics Co Ltd (300685) is listed on SHE in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-28, reported market cap is $8.59B, P/E ratio is 29.64, net margin is 29.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300685
Amoy Diagnostics Co Ltd (300685) — FAQ
What is Amoy Diagnostics Co Ltd's market cap?
Amoy Diagnostics Co Ltd (300685) has a reported market cap of $8.59B (data as of 2026-03-28).
What is 300685's P/E ratio?
The price-to-earnings (P/E) ratio for Amoy Diagnostics Co Ltd (300685) is 29.64 (data as of 2026-03-28).
Does Amoy Diagnostics Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Amoy Diagnostics Co Ltd (300685). Check the MyAverix Finance app for the latest dividend data.
What sector is Amoy Diagnostics Co Ltd in?
Amoy Diagnostics Co Ltd (300685) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 300685 listed on?
300685 is listed on SHE.
What is Amoy Diagnostics Co Ltd's net margin?
Amoy Diagnostics Co Ltd (300685) reports a net margin of 29.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.